Dow Down 0.71% Nasdaq Down 0.63%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
12.09 Down 0.31(2.50%) Sep 23, 4:00PM EDT
Prev Close:12.40
Open:12.38
Bid:N/A
Ask:13.43 x 500
1y Target Est:14.96
Beta:2.06963
Earnings Date:Nov 7 - Nov 11 (Est.)
Day's Range:12.07 - 12.47
52wk Range:6.96 - 18.65
Volume:1,568,635
Avg Vol (3m):1,288,260
Market Cap:1.55B
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HALO

Comparison

Symbol% ChgMkt Cap
HALODown 2.50%1.55B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.91
Quarterly EPS Est (Sep-16) :-0.26
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback